Hematopoietic stem cell donor with IgA nephropathy: Challenges and management algorithm

Transfus Apher Sci. 2020 Aug;59(4):102781. doi: 10.1016/j.transci.2020.102781. Epub 2020 May 8.


Donor safety is of prime importance in allogeneic hematopoietic cell transplantation. The Worldwide Network for Blood and Marrow Transplantation (WBMT) standing committee on donor issues has issued a consensus statement regarding suitability criteria for related adult donors. This committee recommends that donors with a history of immune-mediated glomerulonephritis and abnormal urine tests should preferably undergo bone marrow harvest, to avoid the theoretical risk of granulocyte colony-stimulating factor (G-CSF) induced immune flare-up. We discuss here a unique situation where a related donor with a history of IgA nephropathy (IgAN) insisted on a peripheral blood stem cell harvest. We propose a management plan for this situation, which posed challenges about donor suitability.

Keywords: Apheresis; G-CSF; Hematopoietic cell donor; IgA nephropathy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Glomerulonephritis, IGA / therapy*
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Tissue Donors
  • Transplantation Conditioning / methods*